Ajax Therapeutics
Phase 1About Ajax and our focus on hematologic cancers Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic cancers. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and […]
About
About Ajax and our focus on hematologic cancers Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic cancers. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and […]
Funding History
2Total raised: $190M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile